/
Real World Evidence (RWE) in Japan

Real World Evidence (RWE) in Japan

Project Scope 

Use cases of RWE specific to Japanese industry/regulation:

  • to accelerate drug development

  • for post marketing surveillance (PMS)

  • for preventative actions

Project Statement 

To launch opportunities for sharing use cases of RWE specific to Japanese industry/regulation, because there is a huge gap in the level of understanding and experience among pharmaceutical company staff in Japan. 

Project Impact 

For stakeholders in No. 10, it will be the opportunities for sharing use cases of RWE specific to Japanese industry/regulation, and it will be one way to solve the huge gap in the level of understanding and experience in Japan. 

Project Leads

Email

Yosuke Nishida, Bayer

yasunari.sadatsuki@bayer.com 

Nicola Newton, PHUSE Project Coordinator

nicky@phuse.global 

Click above for the latest project status.

Objectives & Deliverables

Timelines

Plan content

Q2 2026

Report the activites

Q4 2026